Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.59 |
| ▸ | L3MBTL3 | Q96JM7 | 5/20 | 0.56 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.51 |
| ▸ | TP53BP1 | Q12888 | 1/20 | 0.51 |
| ▸ | L3MBTL4 | Q8NA19 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3766156 | 0.88 | USP2 (0.62) | L3MBTL1KDM4EALDH1A1HRH3L3MBTL3 | |
| SCHEMBL3774758 | 0.88 | HRH3 (0.63) | L3MBTL1KDM4EKMT2AHRH3L3MBTL3 | |
| SCHEMBL3770368 | 0.88 | KDM4E (0.67) | L3MBTL1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL3767394 | 0.87 | HRH3 (0.56) | L3MBTL1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL3765288 | 0.87 | HRH3 (0.53) | L3MBTL1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL3769040 | 0.86 | KDM4E (0.67) | L3MBTL1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL3769162 | 0.86 | HTT (0.70) | L3MBTL1KDM4EALDH1A1HRH3L3MBTL3 | |
| SCHEMBL3777456 | 0.86 | KDM4E (0.58) | L3MBTL1KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL3774201 | 0.85 | ALDH1A1 (0.61) | KDM4EALDH1A1MEN1KMT2AHRH3 | |
| SCHEMBL3770102 | 0.85 | MAPT (0.59) | KDM4EALDH1A1MEN1KMT2AHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7851474-B2 | Dipiperazinyl ketones and related analogues | NEUROGEN CORPORATION (US) | 2010-12-14 | — | — | US | disclosed |
| US-7851474-B2 | Dipiperazinyl ketones and related analogues | NEUROGEN CORPORATION (US) | 2010-12-14 | — | — | US | disclosed |
| US-7851474-B2 | Dipiperazinyl ketones and related analogues | NEUROGEN CORPORATION (US) | 2010-12-14 | — | — | US | disclosed |
| US-20070049571-A1 | Dipiperazinyl ketones and related analogues | NEUROGEN CORPORATION | 2007-03-01 | — | — | US | disclosed |
| US-20070049571-A1 | Dipiperazinyl ketones and related analogues | NEUROGEN CORPORATION | 2007-03-01 | — | — | US | disclosed |
| US-20070049571-A1 | Dipiperazinyl ketones and related analogues | NEUROGEN CORPORATION | 2007-03-01 | — | — | US | disclosed |
| WO-2007016496-A2 | DIPIPERAZINYL KETONES AND RELATED ANALOGUES | NEUROGEN CORPORATION (US) | 2007-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049571-A1 | Dipiperazinyl ketones and related analogues | HRH4, HRH3, HRH1 | L3MBTL1 1468/4885KDM4E 534/4885ALDH1A1 1210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.